Current Affairs - Science

Miasma theory was the dominant belief for centuries that diseases like malaria were caused by “bad air” emanating from marshes and decaying matter. It wasn’t until scientific breakthroughs in the late 19th century, such as Alphonse Laveran’s discovery of the malaria parasite in human blood and Ronald Ross's identification of its transmission by mosquitoes, that the actual cause of malaria was understood. The shift from miasma theory to germ theory and parasite transmission not only revolutionized medicine but also had far-reaching impacts on colonial expansion, as better malaria control allowed European powers to colonize vast areas of Africa more effectively.

India has achieved a groundbreaking milestone by initiating its first-in-human gene therapy trial for Haemophilia, marking a significant advancement in its healthcare and biotechnology sectors. The trial is being conducted by BRIC-inStem in collaboration with CMC Vellore and represents a pioneering move toward personalized and precision medicine in the country. This effort highlights India's growing capability in translating scientific research into clinical applications. With rapid expansion in the biotech industry, bolstered by initiatives like the BIO-E3 Policy, India is not only addressing critical health challenges but also reinforcing biotechnology as a pillar of economic growth and national development.

AIIMS Raipur became the first government hospital in Chhattisgarh to successfully perform a Swap Kidney Transplant, setting a new benchmark in the state’s medical capabilities. This significant procedure allows two pairs of incompatible kidney donors and recipients to exchange organs, thereby increasing the potential for successful transplants by around 15%. Beyond this, AIIMS Raipur has also led the way in pioneering deceased donor organ donation and paediatric kidney transplantation within the region. These achievements reflect the hospital’s growing role in advancing complex surgical procedures and improving healthcare access in central India.

The HEALD (Healthy Liver Education and Alcohol-associated Liver Disease Prevention) initiative, launched by Amit Shah, is designed specifically to address liver diseases on a national scale. Its strategy includes public education, early detection, treatment options, and the prevention of liver diseases, especially those linked to alcohol use disorder. The program also integrates psychological support, community engagement, and policy reforms to offer a comprehensive response. The initiative emphasizes the importance of timely intervention, with the strong message that many liver failures result from missed opportunities for early action, underlining the critical need for awareness and prevention efforts.

Gepotidacin is a newly developed antibiotic that was first approved for the treatment of urinary tract infections (UTIs). It functions by inhibiting bacterial replication, which helps to combat bacterial infections effectively. Although it is now being explored as a potential treatment for drug-resistant gonorrhea—a significant development since no new treatments for gonorrhea have emerged since the 1990s—it was originally targeted for UTIs. Its oral form presents a major advancement over the current injectable treatments, making it more accessible and patient-friendly, especially in outpatient settings where ease of use is a crucial factor.